Literature DB >> 3542267

Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand.

L Suebsaeng, W H Wernsdorfer, W Rooney.   

Abstract

Between 1982 and 1984 a regimen consisting of quinine and tetracycline was routinely used in Thailand to treat outpatients with microscopically confirmed falciparum malaria. Due to compliance problems associated with the 7-day multiple-dose regimen, there was a recrudescence rate of approximately 30%. Studies carried out in 1982 and 1984 in four areas of Thailand indicated that there was a significant decrease in the sensitivity of Plasmodium falciparum to quinine. A significant, though less marked, reduction in the sensitivity of P. falciparum to the structurally related drug mefloquine was also observed, although this compound was not operationally deployed in Thailand before 1985. These findings emphasize the need to replace the long multiple-dose quinine regimen by an effective, acceptable, single-dose treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542267      PMCID: PMC2490964     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

  1 in total
  11 in total

Review 1.  Halofantrine: a new substance for treatment of multidrug-resistant malaria.

Authors:  H D Nothdurft; R Clemens; H L Bock; T Löscher
Journal:  Clin Investig       Date:  1993-01

Review 2.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 3.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 4.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

5.  Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia.

Authors:  A Björkman; M Willcox; N Marbiah; D Payne
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

6.  Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.

Authors:  Nantana Suwandittakul; Wanna Chaijaroenkul; Pongchai Harnyuttanakorn; Mathirut Mungthin; Kesara Na Bangchang
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

7.  Synergism between quinine and retinol in fresh isolates of Plasmodium falciparum.

Authors:  Ariane Knauer; Kanungnit Congpuong; Gunther Wernsdorfer; Franz F Reinthaler; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives.

Authors:  M D Bustos; F Gay; B Diquet
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

9.  Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010.

Authors:  Daniel Parker; Rujira Lerdprom; Wanna Srisatjarak; Guiyun Yan; Jetsumon Sattabongkot; James Wood; Jeeraphat Sirichaisinthop; Liwang Cui
Journal:  Malar J       Date:  2012-08-21       Impact factor: 2.979

10.  In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.

Authors:  Wanna Chaijaroenkul; Kesara Na Bangchang; Mathirut Mungthin; Stephen A Ward
Journal:  Malar J       Date:  2005-08-02       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.